All In Biotech

Drug Trial Radar · NCT05084222

Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing

Use of Buventol Easyhaler and Bufomix Easyhaler as Relievers in Methacholine Challenge Testing and Inspiratory Flow Profiles During Induced Bronchoconstriction in Adult Subjects

Last checked: Nov 20, 2026Latest source record: Sep 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

180

Actual

Start

Nov 11, 2021

Primary completion

Jun 30, 2023

Study completion Jun 30, 2023

Sponsor

Sponsor type
Industry
First posted
Oct 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the current standard treatment during methacholine challenge test. The trial will also provide inspiratory flow profile data for Easyhaler inhaler. This trial is designed to provide a further evidence for the use of Easyhaler in diagnostic bronchial challenge tests and on the use of Easyhaler inhaler during obstructive event.

Conditions

  • Asthma

Interventions

  • Buventol® Easyhaler® 200 µg/inhalation dmDPIDrug

    Two doses will be administered

  • Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPIDrug

    Two doses will be administered

  • Ventoline® Evohaler® 100 µg/inhalation pMDIDrug

    Four doses will be administered via Volumatic spacer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Forced expiratory volume in one second (FEV1)Time frame: 10 minutes

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Helsinki University Hospital

    Helsinki, Finland

  • Tampere University Hospital

    Tampere, Finland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.